Cardinal Health (CAH): $63 Price Target From Barclays

By Amit Chowdhry ● Jan 17, 2022
  • The shares of Cardinal Health Inc (NYSE: CAH) have received a $63 price target from Barclays. These are the details.

The shares of Cardinal Health Inc (NYSE: CAH) have received a $63 price target from Barclays. And Barclays analyst Steve Valiquette is maintaining an “Overweight” rating on the company shares.

Valiquette remains positive on the healthcare distribution subsector this year given the upside potential in the out-year from generic/biosimilar pipelines, additional anticipated Covid tailwinds, and the waning risks from other variables previously perceived as overhangs like generic pricing volatility and opioid litigation.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.